Reach Us +1-504-608-2390
Paraneoplastic Vitelliform Retinopathy in Metastatic Cutaneous Melanoma: A Case Series | OMICS International | Abstract
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Case Report

Paraneoplastic Vitelliform Retinopathy in Metastatic Cutaneous Melanoma: A Case Series

Parisa Taravati*, Kathryn Pepple and Russell Van Gelder
Department of Ophthalmology, University of Washington, Seattle, Washington, USA
Corresponding Author : Parisa Taravati
University of Washington Medicine Eye Institute - Box 359608
325 Ninth Avenue, Seattle, WA 98104, USA
Tel: 206-616-1768
Fax: 206-685-9315
E-mail: [email protected]
Received May 12, 2015; Accepted June 25, 2015; Published June 29, 2015
Citation: Taravati P, Pepple K, Gelder RV (2015) Paraneoplastic Vitelliform Retinopathy in Metastatic Cutaneous Melanoma: A Case Series. J Clin Exp Ophthalmol 6:438. doi: 10.4172/2155-9570.1000438
Copyright: © 2014 Taravati P et al., This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google


Paraneoplastic vitelliform retinopathy is a rare condition associated with metastatic melanoma. Like melanomaassociated retinopathy (MAR), it can cause nyctalopia and progressive vision loss; however, unlike MAR, the fundus shows multifocal, yellow-orange vitelliform lesions beneath the neurosensory retina and at the level of the retinal pigment epithelium, as well as areas of subretinal fluid in the macula. The treatment of paraneoplastic vitelliform retinopathy is aimed at the underlying metastatic melanoma but unfortunately has a poor prognosis, with most patients succumbing to their disease. We report two cases of paraneoplastic vitelliform retinopathy in patients with metastatic cutaneous melanoma.